Boston – November 8, 2023 Outcome Capital, a specialized life science advisory and investment banking firm, today announced that Electronic Registry Systems, Inc. (ERS), a leading provider of cancer registry solutions and compliance and informatics services, has been acquired by Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare technology and data analytics company with […]
Read MoreOutcome Capital Life Science Market Pulse October 2023 Click to view our LifeSciences Pulse Newsletter
DownloadOutcome Capital Advises Forward Photonics in its Sale April 24, 2020, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth...
Read MoreOutcome Capital Secures Growth Capital for Whisker Labs November 26, 2019, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies...
Read MoreOutcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science June 4, 2019, Boston, MA...
Read MoreOutcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies May 29, 2019, Reston, VA Outcome Capital, an investment...
Read MoreOutcome Capital Announces Meridian Bioscience Has Acquired GenePOC May 1, 2019, BOSTON, MA –(BUSINESS WIRE)– Outcome Capital, a specialized investment banking firm that serves middle...
Read MoreFederal Data Systems Has Received an Investment from McNally Capital August 30, 2018, Reston, VA Federal Data Systems, Inc (FedData) has received an investment from...
Read MoreOutcome Capital Announces Digital Intelligence Systems Has Acquired Xtreme Consulting Group June 18, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that...
Read MoreJune 1, 2018, Reston, VA & Boston, MA. Outcome Capital (outcomecapital.com), a 20-year-old investment banking boutique that serves the middle market in the technology and...
Read MoreOutcome Capital Announces ATPCO Has Acquired Routehappy February 26, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that serves middle market...
Read MoreOutcome Capital looks forward to attending JP Morgan’s Annual Healthcare Conference in January 2018. If you are interested in meeting to discuss your...
Read MorePlenary Session: Different Approaches VCs Take When Investing in Companies Tuesday, October 24th 2:30 PM – 3:30 PM Location: Grand Ballroom—Salons 1 & 2 (7th...
Read MoreBuilding an Amazing Organization with the Strength of the Right Financial Partners Oded Ben-Joseph, PhD. from Outcome Capital is pleased to take part as...
Read MoreOutcome Capital and Boston University’s BEST Program Partner to Give Scientists Real-Life Experience in the Life Science Sector June 21, 2017, Boston, MA. Outcome Capital,...
Read MoreOutcome Capital Announces UCB Pharma Has Acquired Beryllium Discovery June 6, 2017, Boston, MA. Outcome Capital, an investment banking firm that serves middle market growth...
Read MoreOutcome Capital Congratulates ColonaryConcepts on Sale of Colon Preparation Business Unit to Sebela Pharmaceuticals June 1, 2017, Boston, MA. Outcome Capital (outcomecapital.wpengine.com), a highly specialized investment...
Read MoreDr. Baron’s Extensive Life Science Investment Experience and Deep Knowledge of Emerging Growth Pharma and Biotech Markets Will Bolster Outcome’s Client Service Offerings January 24,...
Read MoreDecember 07, 2016, Boston, MA. Outcome Capital, LLC today announced a collaboration with Suffolk University’s Sawyer Business School aimed at providing graduate-level students with real-world...
Read MoreShawn Manning Appointed Managing Director of London Office September 28, 2016, Boston, MA, USA & London, UK. Outcome Capital, LLC (outcomecapital.wpengine.com), an investment banking firm...
Read MoreSeptember 23, 2016 , Boston, MA. Outcome Capital (outcomecapital.wpengine.com), an investment banking firm that serves middle-market growth companies in life sciences and technology markets, today...
Read MoreDr. Oded Ben-Joseph, Managing Director, has recently published an article in Nature Biotechnology’s August 2016 issue, “Where the Bodies Lie,” about avoiding common mistakes made...
Read MoreWould you like to learn more about working with Outcome Capital or discuss your specific needs?